Loading company…
Beijing-based Sinovac Biotech makes vaccines against diseases including hepatitis A and B, influenza, EV71 and COVID-19 (CoronaVac).
Founded in 2001 and based in Beijing, China, Sinovac Biotech Co. Ltd. researches, makes and sells vaccines for human infectious diseases, including its CoronaVac COVID-19 vaccine. It works with hospitals, research institutions and public health agencies on clinical studies. In July 2018 Advantech Capital and Vivo Capital acquired a 16.6% minority stake, or 5.9 million shares, for USD 86.73 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in